Trials / Completed
CompletedNCT03807544
Treatment Parameters for the Empower Neuromodulation System (ENS)
Study to Optimize and Validate the Treatment Parameters for the Empower Neuromodulation System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Theranova, L.L.C. · Industry
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The subject will be administered a treatment at a treatment location and then be asked if he/she believes it is the active treatment, sham treatment, or does not know. A clinical-grade nerve conduction assessment system will be used both to provide electrical stimulation at four locations to record peripheral responses. The subject will self-administer two treatment sessions at two active treatment sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TENS | Transcutaneous electrical nerve stimulation |
Timeline
- Start date
- 2019-01-15
- Primary completion
- 2019-03-13
- Completion
- 2019-03-13
- First posted
- 2019-01-17
- Last updated
- 2020-11-17
- Results posted
- 2020-03-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03807544. Inclusion in this directory is not an endorsement.